Jiří Slíva, M.D. statins (inhibitors of HMG-CoA reductase) fibrates anion - exchange resins nicotinic acid group.

Slides:

Advertisements

Similar presentations

Agents Used in the Treatment of Hyperlipidemia

Advertisements

Drugs in dyslipidaemias

Drugs used in the treatment of hyperlipidemias

Department of Pharmacology, LSUHSC,

Lipid-lowering drugs. Atherosclerosis and lipoprotein metabolism Atheromatous disease is ubiquitous and underlies the commonest causes of death (e.g.

Drugs and Dyslipidemias (statins and other lipid and atherosclerosis-modifying drugs) October 18, 2006 Frank F. Vincenzi.

Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.

Treatment of Dyslipidemia SDPI CGP Healthy Heart Project March 8, 2006.

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 50 Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol.

Anti-Hypercholesterolemic Agents  Biosynthesis and Metabolism of Cholesterol  What is arteriosclerosis? - Link between arteriosclerosis and cholesterol.

ANTILIPEMICS LILLEY, READING & WORKBOOK: CHAP 28 Cardiovascular System.

Pharmacology of Agents Used in Hyperlipidemia

Antidyslipidemic drugs

HYPERLIPIDEMIAS  Conditions in which the concentrations of cholesterol or triglyceride carrying lipoproteins exceed arbitrary normal limits.

Antiatherosclerosis drugs. Lipid-regulating drugs  Background  Lipoprotein  Classification of Lipoprotein: CM 、 VLDL 、 IDL 、 LDL 、 HDL 、 Lp(a) CM 、

Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 29 Antilipemic Drugs.

The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.

Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.

Kirk Mykytyn, Ph.D. Department of Pharmacology

Department of Family & Community Medicine

Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.

Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.

Antidislipidemic drugs ( Summary ) © Dr Ivan Lambev, PhD Medical University of Sofia, Faculty of Medicine Department.

ANTIHYPERLIPIDEMIC DRUGS

Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.

Antihyperlipidemic Drugs Hyperlipidemias. Hyperlipoproteinemias. Hyperlipemia. Hypercholestrolemia. Direct relationship with acute pancreatitis and atherosclerosis.

Age-standardized prevalence of raised total cholesterol in adults aged 25+ years, by WHO Region and World Bank income group, comparable estimates WHO,

Management & Medications  Diet, weight loss and drug therapy are the mainstay of treatment, while exercise training is used as adjunctive therapy  Lipid-lowering.

Drug therapy for Dyslipidemias

Antihyperlipidemic drugs The clinically important lipoproteins are LDL low density lipoprotein, VLDL very low density lipoprotein, HDL high density lipoprotein.

Part 5 Antiatheroscleotic drugs. §Plasma lipids § Cholesterol free cholesterol (FC) § cholesterolester (CE) § Triglyceride (TG) § Phospholipid (PL)

Step 3 P-treatment: Drug Class Selection. Pharmacological and Non- Pharmacological Management Dyslipidemia drug therapyLifestyle modification Smoking.

Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.

Hypolipidemic Drugs and plasma expanders

Antiatherosclerotic drugs. Learning Objectives: ■ Describe the four main classes of drugs used to treat hyperlipidemia ■ Explain their mechanisms of action,

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Antilipemic Drugs.

Hypolipidemic Drugs.

HLD Tx & AHA/ACC Guidelines

Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.

Management of Hyperlipoprotinaemia

1 HYPOLIPIDAEMICS or LIPID LOWERING DRUGS. 2 Hypolipidaemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used.

Chapter 21 Agents Used in the Treatment of Hyperlipidemia.

Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.

Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.

HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.

50 Drugs that Help Normalize Cholesterol & Triglyceride Levels

Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.

Drugs Used in Hyperlipidemia

LIPID-LOWERING DRUGS Dr. Arwa Mahmood Fuzi Alsarraf.

Agents used in Hyperlipidemia. Objectives: To review the proposed role of lipoprotein in the formation of atherosclerotic plaques. To study various types.

Antihyperlipidemic Drugs

Hypolipidemic Drugs Classification:

Hyperlipidemias.

أبدا لم يفت الاوان لكي تبدأ

Statins induced myopathy

Anti-Hypercholesterolemic Agents

By: Dr Israa Omar MBBS, MRCP, MSc pharmacology

Formative Test.

Anti-Hypercholesterolemic Agents  Biosynthesis and Metabolism of Cholesterol  What is arteriosclerosis? - Link between arteriosclerosis and cholesterol.

18 Dyslipidemia Lect -2- Dr.Hozan.

Antihyperlipidemic Drugs

Anti-Hypercholesterolemic Agents

Biosynthesis and Metabolism of Cholesterol

Antilipidaemic agents

Antihyperlipidemic Drugs

Cardiovascular System

Drugs for Hyperlipidemia

Lipoproteins Macromolecular complexes in the blood that transport lipids Apolipoproteins Proteins on the surface of lipoproteins; they play critical.

ATP III Guidelines Drug Therapy FUTURE RESEARCH.

Presentation transcript:

Jiří Slíva, M.D.

statins (inhibitors of HMG-CoA reductase) fibrates anion - exchange resins nicotinic acid group

HYPOLIPIDEMIKA Aim of treatment: decrease the risk of CVD Target values:TCH < 5 mmol/l LDL < 3 mmol/l TAG < 2 mmol/l HDL > 1 mmol/l hyperlipidaemia –isolated hypercholesterolaemia - statins, (+resins) –combined hyperlipidaemia - fibrates, (+ resins), resins + statins –isolated hypertriacylglycerolaemia - fibrates

STATINS Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzymeA reductase Depletion of CH in the liver -  LDL receptors Stabilization of atherosclerotic plates Decrease of mortality rate I:isolated hypercholesterolaemia, comb. hyperlip. (+fibrates) AE: rare, myopathy, rhabdomyolysis lovastatin, simvastatin, pravastatin, fluvastatin, atorvastatin, (cerivastatin)

FIBRATES Decrease of lipoproteins rich of TAG (VLDL) Increase of HDL cholesterol  expression of gene for apolipoproteins A-I, A-II a C- III and lipoprotein lipase (LPL) AE: cholelithiasis, GIT (nausea, diarrhea), rhabdomyolysis fenofibrate, bezafibrate, gemfibrozile, ciprofibrate

ANION-EXCHANGE RESINS Inhibition of reabsorption of bile acids in bowel -  conversion of chol. onto bile acids -  LDL rec. Synergic effect with statins I: combined hyperlipidaemia, isol. hypercholesterolaemia AE: constipation, flatulent colic, nausea, emesis cholestyramin, colestipol

ACIPIMOX - der. of nicotinic acid inhibition of lipolysis in adipose tissue -  synthesis of VLDL, LDL I: combined hzperlipidaemia NICOTINIC ACID GROUP

Case report: women 58 years old, after IM in 56 years, angina pectoris Th: ASA, ACEI, nitrates; BP: 130/80; P 76/min, 167/70 kg CH-7,6; TG-5,4; HDL-0,85; LDL-6,4 1. Will we indicate lipid-regulating drugs? 2. Is it present medication sufficient? 3. Which kind of hypolipidaemicum is the best? 4. Which laboratory values will we monitor in combination statin + fibrate? 5. What is the aim of therapy?